BALFAXAR Trademark

Trademark Overview

On Thursday, November 21, 2013, a trademark application was filed for BALFAXAR with the United States Patent and Trademark Office. The USPTO has given the BALFAXAR trademark a serial number of 86125467. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 8, 2017. This trademark is owned by Octapharma AG. The BALFAXAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, blood plasma derived products, namely, prothrombin
balfaxar

General Information

Serial Number86125467
Word MarkBALFAXAR
Filing DateThursday, November 21, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 8, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 12, 2014

Trademark Statements

Goods and ServicesPharmaceutical products, namely, blood plasma derived products, namely, prothrombin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 5, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOctapharma AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLachen 8853
CH
Party NameOctapharma AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLachen 8853
CH

Trademark Events

Event DateEvent Description
Monday, May 8, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 8, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 31, 2016EXTENSION 4 GRANTED
Friday, October 7, 2016EXTENSION 4 FILED
Friday, October 7, 2016TEAS EXTENSION RECEIVED
Wednesday, April 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 19, 2016EXTENSION 3 GRANTED
Thursday, April 7, 2016EXTENSION 3 FILED
Thursday, April 7, 2016TEAS EXTENSION RECEIVED
Thursday, October 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 21, 2015EXTENSION 2 GRANTED
Wednesday, October 7, 2015EXTENSION 2 FILED
Wednesday, October 7, 2015TEAS EXTENSION RECEIVED
Wednesday, May 13, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 12, 2015EXTENSION 1 GRANTED
Tuesday, April 7, 2015EXTENSION 1 FILED
Monday, May 11, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 7, 2015TEAS EXTENSION RECEIVED
Tuesday, October 7, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 12, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 12, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 23, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, July 6, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 27, 2014ASSIGNED TO LIE
Wednesday, June 11, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 11, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, June 11, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 11, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, June 11, 2014EXAMINERS AMENDMENT -WRITTEN
Friday, March 14, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 14, 2014NON-FINAL ACTION E-MAILED
Friday, March 14, 2014NON-FINAL ACTION WRITTEN
Friday, March 7, 2014ASSIGNED TO EXAMINER
Thursday, December 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 25, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

balfaxar namely products prothrombin derived blood pharmaceutical plasma